DUX4 vs. PAX7–Who’s the fairest one of all?
[…] years, DUX4 has enjoyed center stage in the yet-unfolding story of facioscapulohumeral muscular dystrophy ( FSHD). DUX4 was first identified in 19991, but only in the past five to 10 […]
Our look is new. Our purpose is the same. Learn more about our brand evolution.
[…] years, DUX4 has enjoyed center stage in the yet-unfolding story of facioscapulohumeral muscular dystrophy ( FSHD). DUX4 was first identified in 19991, but only in the past five to 10 […]
[…] 2017 – Today the FSH Society, a world leader in combating facioscapulohumeral muscular dystrophy ( FSHD), announced it has committed $541,133 in funding to five research projects that aim to […]
[…] can evaluate electrical impedance myography (EIM) as a tool for quantifying the muscle structure of FSHD patients. Today, the FSH Society, a Massachusetts based non-profit that is a world leader in […]
by Jamshid Arjomand, PhD, Chief Science Officer, FSHD Society Our original plan for 2020 was to host the International Research Congress (IRC) in Washington, DC, in proximity to the FDA […]
[…] charitable foundation that has transformed the science of a little-known disease, facioscapulohumeral muscular dystrophy ( FSHD), today announced its Biennial International Network Meeting. The meeting will be the one of […]